Recent Analyst Stock Rating News
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.Get Started for Free
Martin Auster's Stock Ratings
UBS Analyst
Martin Auster is an analyst at UBS. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 06/05/2025
Overall Average Return
4.25%
Smart Score
Overall Average Return Percentile
47th
| Buy Now | Get Alert | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 09/18/2023 | BMRN | Buy Now | Biomarin Pharmaceutical | $55.12 | 117.71% | Martin Auster55% | → $120 | Initiates | → Buy | Get Alert |
| 03/16/2022 | RARE | Buy Now | Ultragenyx Pharmaceutical | $36.91 | 184.48% | Martin Auster55% | $99 → $105 | Upgrade | Neutral → Outperform | Get Alert |
| 12/14/2021 | ARNA | Buy Now | Arena Pharmaceuticals | — | — | Martin Auster55% | $98 → $100 | Downgrade | Outperform → Neutral | Get Alert |
| 04/14/2021 | FLXN | Buy Now | Flexion Therapeutics | — | — | Martin Auster55% | $18 → $17 | Maintains | Outperform | Get Alert |
| 04/13/2021 | ARNA | Buy Now | Arena Pharmaceuticals | — | — | Martin Auster55% | $87 → $102 | Maintains | Outperform | Get Alert |
| 04/06/2021 | RXDX | Buy Now | Prometheus Biosciences | — | — | Martin Auster55% | → $30 | Initiates | → Outperform | Get Alert |
| 03/22/2021 | FULC | Buy Now | Fulcrum Therapeutics | $7.11 | 265.68% | Martin Auster55% | → $26 | Initiates | → Outperform | Get Alert |
| 03/16/2021 | SLDB | Buy Now | Solid Biosciences | $4.20 | 90.48% | Martin Auster55% | $7 → $8 | Maintains | Neutral | Get Alert |
| 03/16/2021 | GLTO | Buy Now | Galecto | $3.15 | 280.95% | Martin Auster55% | $29 → $12 | Maintains | Outperform | Get Alert |
| 03/11/2021 | FLXN | Buy Now | Flexion Therapeutics | — | — | Martin Auster55% | $19 → $18 | Maintains | Outperform | Get Alert |
| 03/10/2021 | STOK | Buy Now | Stoke Therapeutics | $10.88 | 433.09% | Martin Auster55% | $49 → $58 | Maintains | Outperform | Get Alert |
| 02/22/2021 | UTHR | Buy Now | United Therapeutics | $319.71 | -38.69% | Martin Auster55% | $169 → $196 | Maintains | Outperform | Get Alert |
| 02/11/2021 | ALXO | Buy Now | ALX Oncology Holdings | $0.52 | 18691.95% | Martin Auster55% | $62 → $98 | Maintains | Outperform | Get Alert |
| 01/19/2021 | INSM | Buy Now | Insmed | $70.90 | -15.37% | Martin Auster55% | $50 → $60 | Maintains | Outperform | Get Alert |
| 01/11/2021 | SRRK | Buy Now | Scholar Rock Holding | $34.17 | 90.23% | Martin Auster55% | → $65 | Initiates | → Outperform | Get Alert |
| 01/08/2021 | SRPT | Buy Now | Sarepta Therapeutics | $39.40 | 85.28% | Martin Auster55% | $156 → $73 | Maintains | Neutral | Get Alert |
| 01/08/2021 | SLDB | Buy Now | Solid Biosciences | $4.20 | 66.67% | Martin Auster55% | → $7 | Upgrade | Underperform → Neutral | Get Alert |
| 12/14/2020 | SRPT | Buy Now | Sarepta Therapeutics | $39.40 | 295.94% | Martin Auster55% | $162 → $156 | Maintains | Neutral | Get Alert |
| 12/10/2020 | CVAC | Buy Now | CureVac | $4.45 | — | Martin Auster55% | — | Downgrade | Neutral → Underperform | Get Alert |
| 11/23/2020 | GLTO | Buy Now | Galecto | $3.15 | 820.63% | Martin Auster55% | → $29 | Initiates | → Outperform | Get Alert |
| 11/20/2020 | QURE | Buy Now | uniQure | $16.76 | 365.43% | Martin Auster55% | $76 → $78 | Maintains | Outperform | Get Alert |
| 11/13/2020 | STOK | Buy Now | Stoke Therapeutics | $10.88 | 350.37% | Martin Auster55% | $42 → $49 | Maintains | Outperform | Get Alert |
| 11/10/2020 | ESPR | Buy Now | Esperion Therapeutics | $1.18 | — | Martin Auster55% | — | Upgrade | Neutral → Outperform | Get Alert |
| 11/06/2020 | SRPT | Buy Now | Sarepta Therapeutics | $39.40 | 311.17% | Martin Auster55% | $167 → $162 | Maintains | Neutral | Get Alert |
| 10/28/2020 | ALXN | Buy Now | Alexion Pharmaceuticals | — | — | Martin Auster55% | → $133 | Initiates | → Neutral | Get Alert |
| 10/08/2020 | KURA | Buy Now | Kura Oncology | $6.44 | 567.7% | Martin Auster55% | $27 → $43 | Maintains | Outperform | Get Alert |
| 10/06/2020 | MYOK | Buy Now | MyoKardia | — | — | Martin Auster55% | → $225 | Downgrade | Outperform → Neutral | Get Alert |
| 09/08/2020 | CVAC | Buy Now | CureVac | $4.45 | 1428.09% | Martin Auster55% | → $68 | Initiates | → Neutral | Get Alert |
| 08/20/2020 | SRPT | Buy Now | Sarepta Therapeutics | $39.40 | 323.86% | Martin Auster55% | $185 → $167 | Downgrade | Outperform → Neutral | Get Alert |
| 08/11/2020 | ALXO | Buy Now | ALX Oncology Holdings | $0.52 | 10062.99% | Martin Auster55% | → $53 | Initiates | → Outperform | Get Alert |
| 08/11/2020 | ESPR | Buy Now | Esperion Therapeutics | $1.18 | 3713.56% | Martin Auster55% | $83 → $45 | Downgrade | Outperform → Neutral | Get Alert |
| 08/07/2020 | XLRN | Buy Now | Acceleron Pharma | — | — | Martin Auster55% | $134 → $135 | Maintains | Outperform | Get Alert |
| 07/29/2020 | FLXN | Buy Now | Flexion Therapeutics | — | — | Martin Auster55% | → $19 | Initiates | → Outperform | Get Alert |
| 07/07/2020 | RNA | Buy Now | Avidity Biosciences | $35.59 | -4.47% | Martin Auster55% | → $34 | Initiates | → Outperform | Get Alert |
| 07/07/2020 | KURA | Buy Now | Kura Oncology | $6.44 | 319.25% | Martin Auster55% | → $27 | Initiates | → Outperform | Get Alert |
| 07/01/2020 | RARE | Buy Now | Ultragenyx Pharmaceutical | $36.91 | 73.39% | Martin Auster55% | $60 → $64 | Maintains | Neutral | Get Alert |
| 06/25/2020 | UTHR | Buy Now | United Therapeutics | $319.71 | -54.65% | Martin Auster55% | $129 → $145 | Maintains | Outperform | Get Alert |
| 06/25/2020 | XLRN | Buy Now | Acceleron Pharma | — | — | Martin Auster55% | $123 → $134 | Maintains | Outperform | Get Alert |
| 06/02/2020 | NTLA | Buy Now | Intellia Therapeutics | $7.55 | 178.15% | Martin Auster55% | $19 → $21 | Maintains | Neutral | Get Alert |
| 05/08/2020 | XLRN | Buy Now | Acceleron Pharma | — | — | Martin Auster55% | $99 → $123 | Maintains | Outperform | Get Alert |
| 05/07/2020 | ANAB | Buy Now | AnaptysBio | $20.75 | -22.89% | Martin Auster55% | $14 → $16 | Maintains | Neutral | Get Alert |
| 03/17/2020 | INSM | Buy Now | Insmed | $70.90 | -40.76% | Martin Auster55% | $49 → $42 | Maintains | Outperform | Get Alert |
| 01/28/2020 | XLRN | Buy Now | Acceleron Pharma | — | — | Martin Auster55% | $58 → $99 | Maintains | Outperform | Get Alert |
| 12/10/2019 | FTSV | Buy Now | Forty Seven | — | — | Martin Auster55% | $18 → $38 | Maintains | Outperform | Get Alert |
| 12/05/2019 | FTSV | Buy Now | Forty Seven | — | — | Martin Auster55% | $15 → $18 | Reiterates | → Outperform | Get Alert |
| 07/15/2019 | STOK | Buy Now | Stoke Therapeutics | $10.88 | 221.69% | Martin Auster55% | → $35 | Initiates | → Outperform | Get Alert |
| 05/17/2019 | UTHR | Buy Now | United Therapeutics | $319.71 | -70.6% | Martin Auster55% | $115 → $94 | Upgrade | Sell → Neutral | Get Alert |
| 05/14/2019 | SLDB | Buy Now | Solid Biosciences | $4.20 | 42.86% | Martin Auster55% | $7 → $6 | Downgrade | Neutral → Underperform | Get Alert |
| 10/29/2018 | RARE | Buy Now | Ultragenyx Pharmaceutical | $36.91 | 59.85% | Martin Auster55% | $78 → $59 | Maintains | Neutral | Get Alert |
| 09/06/2018 | SLDB | Buy Now | Solid Biosciences | $4.20 | 804.76% | Martin Auster55% | → $38 | Initiates | → Neutral | Get Alert |
| 08/08/2018 | ONCE | Buy Now | Spark Therapeutics | — | — | Martin Auster55% | $80 → $53 | Maintains | Neutral | Get Alert |
| 07/23/2018 | FTSV | Buy Now | Forty Seven | — | — | Martin Auster55% | → $24 | Initiates | → Outperform | Get Alert |
| 06/21/2018 | RARE | Buy Now | Ultragenyx Pharmaceutical | $36.91 | 116.74% | Martin Auster55% | $67 → $80 | Downgrade | Outperform → Neutral | Get Alert |
| 04/12/2018 | AVXS | Buy Now | AveXis | — | — | Martin Auster55% | — | Downgrade | Buy → Neutral | Get Alert |
| 01/17/2018 | RARE | Buy Now | Ultragenyx Pharmaceutical | $36.91 | 81.52% | Martin Auster55% | → $67 | Initiates | → Outperform | Get Alert |
| 12/12/2017 | ONCE | Buy Now | Spark Therapeutics | — | — | Martin Auster55% | — | Downgrade | Buy → Neutral | Get Alert |
| 03/30/2017 | AVXS | Buy Now | AveXis | — | — | Martin Auster55% | — | Initiates | → Buy | Get Alert |
| 03/30/2017 | ONCE | Buy Now | Spark Therapeutics | — | — | Martin Auster55% | — | Initiates | → Buy | Get Alert |
| 03/30/2017 | ALXN | Buy Now | Alexion Pharmaceuticals | — | — | Martin Auster55% | — | Initiates | → Buy | Get Alert |
| 03/30/2017 | BMRN | Buy Now | Biomarin Pharmaceutical | $55.12 | 66.91% | Martin Auster55% | → $92 | Initiates | → Neutral | Get Alert |
| 03/30/2017 | UTHR | Buy Now | United Therapeutics | $319.71 | -64.97% | Martin Auster55% | → $112 | Initiates | → Sell | Get Alert |
| 02/09/2016 | RARE | Buy Now | Ultragenyx Pharmaceutical | $36.91 | 187.19% | Martin Auster55% | $135 → $106 | Maintains | Outperform | Get Alert |
| 01/20/2016 | RARE | Buy Now | Ultragenyx Pharmaceutical | $36.91 | 265.75% | Martin Auster55% | → $135 | Initiates | → Outperform | Get Alert |
| 12/11/2014 | BMRN | Buy Now | Biomarin Pharmaceutical | $55.12 | 103.19% | Martin Auster55% | $87 → $112 | Maintains | Buy | Get Alert |
| 06/11/2014 | BMRN | Buy Now | Biomarin Pharmaceutical | $55.12 | 34.25% | Martin Auster55% | → $74 | Initiates | → Buy | Get Alert |
| 04/30/2014 | BMRN | Buy Now | Biomarin Pharmaceutical | $55.12 | 32.44% | Martin Auster55% | $76 → $73 | Maintains | Buy | Get Alert |
| 02/01/2013 | BMRN | Buy Now | Biomarin Pharmaceutical | $55.12 | 21.55% | Martin Auster55% | $53 → $67 | Maintains | Buy | Get Alert |
| 10/25/2012 | ALXN | Buy Now | Alexion Pharmaceuticals | — | — | Martin Auster55% | $120 → $122 | Maintains | Buy | Get Alert |
| 07/26/2012 | ALXN | Buy Now | Alexion Pharmaceuticals | — | — | Martin Auster55% | $99 → $120 | Maintains | Buy | Get Alert |
| 04/12/2012 | BMRN | Buy Now | BioMarin Pharmaceuticals | $55.12 | -21.99% | Martin Auster55% | → $43 | Initiates | → Buy | Get Alert |
| 02/23/2012 | ALXN | Buy Now | Alexion Pharmaceuticals | — | — | Martin Auster55% | $73 → $99 | Upgrade | Neutral → Buy | Get Alert |
